A detailed history of Columbia Trust CO 01012016 transactions in Geron Corp stock. As of the latest transaction made, Columbia Trust CO 01012016 holds 10,000 shares of GERN stock, worth $34,900. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$34,900
Previous $21,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 11, 2022

BUY
$1.67 - $2.94 $16,700 - $29,400
10,000 New
10,000 $23,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.32B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Columbia Trust CO 01012016 Portfolio

Follow Columbia Trust CO 01012016 and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Trust CO 01012016, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Trust CO 01012016 with notifications on news.